Download our app.

Moderna Sets phase 3 Vaccine Trials for the 27th of July

Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

All told, around 30,000 adults of both sexes will be recruited for the study, which should run for approximately three months. Participants will receive one intramuscular injection of either 100 micrograms of mRNA-1273 or a placebo on day 1 and on day 29. The trial will be conducted across 87 locations throughout the U.S.

If the trial launches on time, it would fulfill a promise made by Moderna of a July start. Earlier this month, there was speculation that the phase 3 trial would be delayed due to the company’s modifications of the testing protocol. There were also reports that Moderna and government health officials were at odds over various aspects of the trials, although both sides maintain this isn’t the case.

The company, which is relatively new compared to larger peers who are also developing coronavirus vaccine candidates, has never conducted a clinical trial of this size. And unlike many of those rivals, it has never had a single product approved.

Yet the results it has released from earlier testing on mRNA-1273 are very encouraging, and the vaccine candidate is moving rather quickly through the clinical trials process. As a result, numerous healthcare experts and industry observers believe Moderna has a strong chance of being the first to market with a coronavirus vaccine.

Últimas Noticias

Language

Latests News

Accomodations

Tours

Rentals

Experiences

Culture/Art

Restaurants

Shop

Prices

Assistance

(Premium)

Emergency

(Tap 3 Times)

Get a Quotation

We work and have contact with several hotel, agencies and tour operators. If you are planning a group travel or your company is looking for incentives and rewards contact us and we will pass as your inquiry to several providers. This service is completely free.

Paradise Costa Rica

FREE
VIEW